Aratana Therapeutics, Inc., a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, plans on presenting at the Stifel Dental & Veterinary Conference on Wednesday, May 29, 2019 at 8:00 a.m. ET in New York City.
LEAWOOD, Kan., May 7, 2019 /PRNewswire/ -- Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, plans on presenting at the Stifel Dental & Veterinary Conference on Wednesday, May 29, 2019 at 8:00 a.m. ET in New York City.
Interested parties may listen to the webcast live or access the audio link for up to 90 days after the meeting. Presentation slides from the conference will also be available in the Aratana Investor Room.
About Aratana Therapeutics
Aratana Therapeutics is a pet therapeutics company focused on developing and commercializing innovative therapeutics for dogs and cats. Our mission is to successfully develop and deliver best-in-class therapeutics, provide comprehensive service to veterinarians and serve as a collaborator of choice for human and animal health companies. We believe our therapeutics are highly differentiated, resolve recognizable needs in compelling markets and have therapeutic profiles superior to the standard of care. For more information, please visit www.aratana.com.
Contacts
For investor inquires:
Rhonda Hellums
ir@aratana.com
(913) 353-1026
For media inquiries:
Rachel Reiff
media@aratana.com
(913) 353-1050
View original content to download multimedia:http://www.prnewswire.com/news-releases/aratana-therapeutics-to-present-at-stifel-2019-dental--veterinary-conference-300844569.html
SOURCE Aratana Therapeutics
Company Codes: NASDAQ-NMS:PETX
